aNeedles are sold separately and may require a prescription in some states.
bManaged care plans only. Does not include Medicaid and Medicaid Part D. Intended as a guide. Lower acquisition costs alone do not necessarily reflect a cost advantage in the outcome of the condition treated because there are other variables that affect relative cost. Formulary status is subject to change.
Needles are sold separately and may require a prescription in some states. Never share a NovoLog® FlexPen, NovoLog® FlexTouch®, PenFill® cartridge, or PenFill® cartridge device between patients, even if the needle is changed. Sharing poses a risk for transmission of blood-borne pathogens.
cMulticenter, randomized, open-label, 2-period, crossover trial in insulin-treated patients with diabetes (type 1 or type 2). Patients were randomized to self administer insulin injections with one needle type followed by the alternative, each for 7 to 14 days. The 2 needle types used were NovoFine® 32-gauge tip x 6 mm and NovoFine® 30-gauge tip x 8 mm.4
dPenFill® cartridges in use (opened) must NOT be stored in the refrigerator.
eVials in use (opened) may be stored in the refrigerator until the label expiration date.
Thought leaders talk about bolus insulin therapy, from the role of PPG control in helping to reach A1C goals to improving patient engagement.
NovoLog® (insulin aspart injection) 100 U/mL is an insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.
NovoLog® continuous subcutaneous infusion route (insulin pump): Do not mix NovoLog® with any other insulin or diluent.
Please click here for Prescribing Information.